Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal
Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer
Tyrosine Kinase Inhibitor Encoraging For NSCLC
Novel Agents Promise Relief From Hematologic Side Effects
Interferon Alpha-2B Effective For Malignant Melanoma
International Group Plans Survey On Thrombosis Risk
NCI-Approved Clinical Trials Listed For June 2001
Trending Stories
- Edward Sondik, electrical engineer turned public health expert and one-time interim NCI director, dies at 82
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Trump et al. are wrong: Biden Cancer Initiative is not to be confused with the Beau Biden Cancer Moonshot
- NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission